Using a Wireless Controller to Deliver a Lighting Intervention to Persons With Dementia
| 适应症 | Alzheimer's Disease |
|---|---|
| 分期 | 不适用 |
| 申办方 | Icahn School of Medicine at Mount Sinai |
| 状态 | 已完成 |
| 受试者人数 | 14 人 |
| 干预（药物） | Active lighting intervention, Control lighting intervention |
| 开始日期 | 2022年1月6日 |
| 完成日期 | 2023年5月1日 |
| 结果公布日 | 2026年7月30日 |
摘要
To test the effect of a tailored lighting intervention controlled by the Readings At Desk (RAD) controller on sleep and mood in Alzheimer's disease participants.
Sleep Disturbance Using the Pittsburgh Sleep Quality Index (PSQI)
| Active Lighting Intervention | 6.5 ± 4.3 Score on a scale |
|---|---|
| Control Lighting | 4 ± 2.3 Score on a scale |
| Active Lighting Intervention | 4.1 ± 2.3 Score on a scale |
| Control Lighting | 6 ± 3.3 Score on a scale |
在 BENITIONS 中查看 查看 ClinicalTrials.gov 原文
同一适应症的其他试验
- Brain Energy for Amyloid Transformation in Alzheimer's Disease Study — Wake Forest University Health Sciences
- Clinical Trial of Solanezumab for Older Individuals Who May be at Risk for Memory Loss — Eli Lilly and Company
- Deprescribing in Patients Living With Dementia With Caregiver and Provider Nudges — Brigham and Women's Hospital
- Technology and Family Thriving Study — University of California, Santa Barbara
- Community-based Brain Health Program to Address Dementia Risk — Posit Science Corporation
- Impact of Nilotinib on Safety, Biomarkers and Clinical Outcomes in Mild to Moderate Alzhei — Georgetown University